Cargando…

Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway

Yes-associated protein 1 (YAP1) stimulates cell proliferation, epithelial-to-mesenchymal transition, invasion and metastasis in several cancers. Here, we investigated the involvement of YAP1 in papillary thyroid carcinoma (PTC) by assessing YAP1 mRNA and protein levels in PTC tissues and matched nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Tian, Wen, Duo, Ma, Ben, Hu, Jia-Qian, Qu, Ning, Shi, Rong-Liang, Liu, Liang, Guan, Qing, Li, Duan-Shu, Ji, Qing-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355298/ https://www.ncbi.nlm.nih.gov/pubmed/28036290 http://dx.doi.org/10.18632/oncotarget.14319

Ejemplares similares

Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway
por: Liao, Tian, et al.
Publicado: (2018)

PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer
por: Liu, Wan-Lin, et al.
Publicado: (2021)

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
por: Liao, Tian, et al.
Publicado: (2016)

Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma
por: Lu, Zhong-Wu, et al.
Publicado: (2020)

Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β‐catenin signaling and sensitizes cancer cells to FH535 therapy
por: Wen, Duo, et al.
Publicado: (2018)

Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer
por: Zhang, Hui-Min, et al.
Publicado: (2022)

Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis
por: Qu, Ning, et al.
Publicado: (2016)

Number of tumor foci predicts prognosis in papillary thyroid cancer
por: Qu, Ning, et al.
Publicado: (2014)

Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma
por: Lin, Dao-zhe, et al.
Publicado: (2016)

IL-2 enhanced MHC class I expression in papillary thyroid cancer with Hashimoto's thyroiditis overcomes immune escape in vitro
por: Hu, Jia-Qian, et al.
Publicado: (2020)

CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways
por: Yu, Shi-Tong, et al.
Publicado: (2018)

IL-10 Restores MHC Class I Expression and Interferes With Immunity in Papillary Thyroid Cancer With Hashimoto Thyroiditis
por: Lu, Zhong-Wu, et al.
Publicado: (2020)

The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer
por: Shi, Rong‐liang, et al.
Publicado: (2016)

The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer
por: Shi, Rong-liang, et al.
Publicado: (2016)

Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model
por: Shi, Rong-liang, et al.
Publicado: (2016)

IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto’s thyroiditis
por: Han, Li-Tao, et al.
Publicado: (2019)

miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway
por: Hai, Rui, et al.
Publicado: (2022)

TFF3 Contributes to Epithelial-Mesenchymal Transition (EMT) in Papillary Thyroid Carcinoma Cells via the MAPK/ERK Signaling Pathway
por: Lin, Xu, et al.
Publicado: (2018)

Prognostic and clinical significance of HOXC9 and HOXD10 in papillary thyroid cancer
por: Cao, Yi-Ming, et al.
Publicado: (2021)

NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer
por: Zhang, Ting-Ting, et al.
Publicado: (2018)

Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis
por: Zhang, Ting-ting, et al.
Publicado: (2017)

The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma
por: Hu, Jia‐Qian, et al.
Publicado: (2019)

Prognostic significance and optimal cutoff of age in medullary thyroid cancer
por: Qu, Ning, et al.
Publicado: (2016)

CITED1 promotes proliferation of papillary thyroid cancer cells via the regulation of p21 and p27
por: Li, Hai, et al.
Publicado: (2018)

Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway
por: Jin, Jun-Qing, et al.
Publicado: (2021)

Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2016)

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer
por: Du, Pengcheng, et al.
Publicado: (2019)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Corrigendum: Long intergenic non-coding RNA 271 is predictive of a poorer prognosis of papillary thyroid cancer
por: Ma, Ben, et al.
Publicado: (2017)

MAPK-ERK Pathway
por: Park, Jong-In
Publicado: (2023)

Influence of miR-101 on proliferation of liver cancer cells through the MAPK/ERK signaling pathway
por: Meng, Xuan, et al.
Publicado: (2020)

CRLF1–MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis
por: Yu, Shi-Tong, et al.
Publicado: (2020)

The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease
por: Zhang, Ling, et al.
Publicado: (2012)

The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma
por: Wang, Nanpeng, et al.
Publicado: (2018)

Hypervascularity is more frequent in medullary thyroid carcinoma: Compared with papillary thyroid carcinoma
por: Lai, Xingjian, et al.
Publicado: (2016)

CLDN8 promotes colorectal cancer cell proliferation, migration, and invasion by activating MAPK/ERK signaling
por: Cheng, Bo, et al.
Publicado: (2019)

Effect of MALAT1 Polymorphisms on Papillary Thyroid Cancer in a Chinese Population
por: Wen, Jing, et al.
Publicado: (2019)

Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway
por: Wu, Qiong, et al.
Publicado: (2021)

Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways
por: Yu, Ze-Yuan, et al.
Publicado: (2020)

Correlation of ERK/MAPK signaling pathway with proliferation and apoptosis of colon cancer cells
por: Zhou, Gang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_883bhoahtb7k8ufsfu9egonbg0